Target intelligence / Profile preview

High mobility group AT-hook 1 pseudogene 8 (HMGA1P8)

Target
HMGA1P8
Molecular classification
Pseudogene, Processed pseudogene, Non-coding RNA, Other
01

Overview

HMGA1P8 (HMGA1-p) is one of eight processed pseudogenes of HMGA1 in the human genome. While it does not encode a protein, HMGA1-p has emerged as a functional RNA that can regulate gene expression through competitive binding to RNA stability factors (specifically αCP1), thereby destabilizing HMGA1 mRNA. Overexpression of HMGA1-p has been shown to decrease HMGA1 protein levels, leading to reduced expression of insulin receptor (INSR) and contributing mechanistically to insulin resistance and type 2 diabetes mellitus. There is also evidence of its involvement in cancer via epigenetic and miRNA-mediated regulatory pathways. Unlike canonical therapeutic targets, HMGA1-p operates chiefly through RNA-mediated gene regulation and is not targetable by traditional pharmacological agents.

Other names
HMGA1-pHMGA1 pseudogene 8
02

Mechanism of action

Not applicable; as a pseudogene, it is not a protein target for drugs, but it functions by competing for RNA-binding and stability factors (not classical target-drug mechanisms)

03

Biological functions

Post-transcriptional regulation of gene expressionRegulation of HMGA1 mRNA stability via competitive binding to RNA stability factor αCP1Modulation of cell metabolism via HMGA1 and INSR expression
04

Disease associations

Type 2 diabetes mellitus (linked to insulin resistance through regulation of INSR expression)Cancer (epigenetic regulation affecting HMGA1, which contributes to oncogenesis and tumor progression)
05

Safety considerations

None reported specific to the pseudogene as a therapeutic target. Since it is not targeted by drugs, traditional safety concerns of target-based therapeutics do not apply.
06

Biomarkers

Evaluation of HMGA1-p expression may serve as a potential epigenetic biomarker for diabetes (insulin resistance)Possible diagnostic or prognostic marker in some cancers

Beyond the preview

Go deeper on High mobility group AT-hook 1 pseudogene 8 (HMGA1P8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group AT-hook 1 pseudogene 8 (HMGA1P8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call